CHEMM Stock Overview
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
ChemoMetec A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.371.60 |
| 52 Week High | kr.554.00 |
| 52 Week Low | kr.255.00 |
| Beta | 1.26 |
| 1 Month Change | 29.75% |
| 3 Month Change | -19.18% |
| 1 Year Change | -14.85% |
| 3 Year Change | -50.19% |
| 5 Year Change | 143.51% |
| Change since IPO | 1,589.09% |
Recent News & Updates
Recent updates
Some Confidence Is Lacking In ChemoMetec A/S (CPH:CHEMM) As Shares Slide 32%
Apr 15
What ChemoMetec A/S' (CPH:CHEMM) 30% Share Price Gain Is Not Telling You
Mar 01What Does ChemoMetec A/S's (CPH:CHEMM) Share Price Indicate?
Mar 01Earnings Beat: ChemoMetec A/S Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 08Unpleasant Surprises Could Be In Store For ChemoMetec A/S' (CPH:CHEMM) Shares
Dec 21Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?
Nov 15ChemoMetec A/S (CPH:CHEMM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Sep 17A Look At The Intrinsic Value Of ChemoMetec A/S (CPH:CHEMM)
Sep 15At kr.467, Is ChemoMetec A/S (CPH:CHEMM) Worth Looking At Closely?
Jun 20With EPS Growth And More, ChemoMetec (CPH:CHEMM) Makes An Interesting Case
Jun 01Here's Why ChemoMetec (CPH:CHEMM) Has Caught The Eye Of Investors
Jan 24If EPS Growth Is Important To You, ChemoMetec (CPH:CHEMM) Presents An Opportunity
Oct 26Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?
Oct 05Does ChemoMetec (CPH:CHEMM) Deserve A Spot On Your Watchlist?
Jul 18Here's Why I Think ChemoMetec (CPH:CHEMM) Is An Interesting Stock
Mar 27Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?
Dec 12Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today
Aug 29Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today
Apr 28ChemoMetec A/S' (CPH:CHEMM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 18ChemoMetec (CPH:CHEMM) Is Growing Earnings But Are They A Good Guide?
Feb 10What Type Of Shareholders Make Up ChemoMetec A/S' (CPH:CHEMM) Share Registry?
Jan 15
Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?
Dec 20ChemoMetec A/S' (CPH:CHEMM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?
Nov 22Shareholder Returns
| CHEMM | DK Life Sciences | DK Market | |
|---|---|---|---|
| 7D | 1.9% | -2.9% | 1.6% |
| 1Y | -14.8% | -14.0% | 30.0% |
Return vs Industry: CHEMM matched the Danish Life Sciences industry which returned -14% over the past year.
Return vs Market: CHEMM underperformed the Danish Market which returned 30% over the past year.
Price Volatility
| CHEMM volatility | |
|---|---|
| CHEMM Average Weekly Movement | 10.3% |
| Life Sciences Industry Average Movement | 6.0% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in DK Market | 10.2% |
| 10% least volatile stocks in DK Market | 3.0% |
Stable Share Price: CHEMM's share price has been volatile over the past 3 months.
Volatility Over Time: CHEMM's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Danish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 171 | Martin Behrens | chemometec.com |
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in are areas of cell-based therapy, cancer, and stem cell research, development, and manufacturing of pharmaceuticals as well as production and quality control of animal semen and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; NucleoCounter SCC-100, a somatic cell counter used to measure the number of somatic cells in a milk sample; and NucleoCounter YC-100, an automated yeast cell counter used to measure the total cell count and viability of yeast cells in suspension.
ChemoMetec A/S Fundamentals Summary
| CHEMM fundamental statistics | |
|---|---|
| Market cap | kr.6.25b |
| Earnings (TTM) | kr.143.80m |
| Revenue (TTM) | kr.401.54m |
45.0x
P/E Ratio16.1x
P/S RatioIs CHEMM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CHEMM income statement (TTM) | |
|---|---|
| Revenue | kr.401.54m |
| Cost of Revenue | kr.47.43m |
| Gross Profit | kr.354.11m |
| Other Expenses | kr.210.31m |
| Earnings | kr.143.80m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 11, 2024
| Earnings per share (EPS) | 8.26 |
| Gross Margin | 88.19% |
| Net Profit Margin | 35.81% |
| Debt/Equity Ratio | 0.2% |
How did CHEMM perform over the long term?
See historical performance and comparison